Context: Towards strengthening the emerging biotechnology enterprise in India, Department of Biotechnology (DBT), has initiated the Cabinet approved National Biopharma Mission entitled: “Industry-Academia Collaborative Mission for Accelerating Discovery Research to Early Development for Biopharmaceuticals – Innovate in India Empowering biotech entrepreneurs & accelerating inclusive innovation”.
About National Biopharma Mission (NBM)
- It is an industry-academia collaborative mission for accelerating biopharmaceutical development in the country.
- It is being implemented by the Biotechnology Industry Research Assistance Council (BIRAC), which is a Public Sector Enterprise, set up by the Department of Biotechnology (DBT).
- Under this Mission, the Government has launched Innovate in India (i3) programme to create an enabling ecosystem to promote entrepreneurship and indigenous manufacturing in the biopharma sector.
The approved objectives of the Mission are :-
- Development of products from leads that are at advanced stages in the product development lifecycle and relevant to the public health.
- Strengthening and establishing shared infrastructure facilities for both product discovery validation and manufacturing
- Developing human capital by providing specific training to address the critical skills gaps in researchers, nascent biotech companies across the product development value chain, including in business plan development and market penetration.
- Creating and enhancing technology transfer and intellectual property management capacities and capabilities in public and private sector.